Literature DB >> 23735325

Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture.

Chengjuan Qu1, Katja A Puttonen, Heli Lindeberg, Marika Ruponen, Outi Hovatta, Jari Koistinaho, Mikko J Lammi.   

Abstract

Chondrogenic differentiation of human embryonic (hESCs) or induced pluripotent stem cells (hiPSCs) has been achieved in embryoid bodies (EBs) by adding selected growth factors to the medium. Also chondrocyte-secreted factors have been considered to promote the chondrogenic differentiation. Hence, we studied whether co-culture with primary chondrocytes can induce hESCs or hiPSCs to differentiate into chondrocyte lineage. Co-culture of hESCs or hiPSCs was established in a transwell insert system in feeder-free culture conditions, while hESCs or hiPSCs grown alone in the wells were used as controls. After 3-week co-culture with weekly replenished chondrocytes, the chondrogenically committed cells (hCCCs) were evaluated by morphology, immunocytochemistry, quantitative real-time RT-PCR, and analysis of chondrogenic, osteogenic and adipogenic differentiation markers. The expressions of chondrocyte- and pluripotency-associated genes were frequently measured during the monolayer expansion of hCCCs from passage 1 to 10. Human CCCs displayed morphology similar to chondrocytes, and expressed chondrocyte-associated genes, which were declined following passaging, similarly to passaged chondrocytes. They also formed a chondrogenic cell pellet, and differentiated into chondrocytic cells, which secreted abundant extracellular matrix. Human CCCs also proliferated rapidly. However, they did not show osteogenic or adipogenic differentiation capacity. Our results show that co-culture of hESCs or hiPSCs with primary chondrocytes could induce specific chondrogenic differentiation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (Induced) pluripotent stem cells; Chondrocytes; Chondrogenic differentiation; Co-culture; Human chondrogenically committed cells

Mesh:

Substances:

Year:  2013        PMID: 23735325     DOI: 10.1016/j.biocel.2013.05.029

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

Review 1.  Concise review: animal substance-free human embryonic stem cells aiming at clinical applications.

Authors:  Outi Hovatta; Sergey Rodin; Liselotte Antonsson; Karl Tryggvason
Journal:  Stem Cells Transl Med       Date:  2014-10-08       Impact factor: 6.940

2.  Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells.

Authors:  Yueying Li; Yong Hai; Jiayu Chen; Tie Liu
Journal:  J Vis Exp       Date:  2017-07-18       Impact factor: 1.355

3.  Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspectives.

Authors:  Shahrbano Jahangir; Mojtaba Khozaei Ravari; Leila Taghiyar; Mohammad Amin Shamekhi; Mohamadreza Baghaban Eslaminejad
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

Authors:  Arun Sharma; Samuel Sances; Michael J Workman; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2020-03-05       Impact factor: 24.633

5.  Induced pluripotent stem cells in cartilage repair.

Authors:  Steven A Lietman
Journal:  World J Orthop       Date:  2016-03-18

6.  Generation of Functional Neuromuscular Junctions from Human Pluripotent Stem Cell Lines.

Authors:  Katja A Puttonen; Marika Ruponen; Nikolay Naumenko; Outi H Hovatta; Pasi Tavi; Jari Koistinaho
Journal:  Front Cell Neurosci       Date:  2015-12-08       Impact factor: 5.505

7.  Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells.

Authors:  Juha Piltti; Joakim Bygdell; Cecilia Fernández-Echevarría; Daniel Marcellino; Mikko J Lammi
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

Review 8.  Extracellular matrix production in vitro in cartilage tissue engineering.

Authors:  Jie-Lin Chen; Li Duan; Weimin Zhu; Jianyi Xiong; Daping Wang
Journal:  J Transl Med       Date:  2014-04-05       Impact factor: 5.531

9.  PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease.

Authors:  Minna Oksanen; Andrew J Petersen; Nikolay Naumenko; Katja Puttonen; Šárka Lehtonen; Max Gubert Olivé; Anastasia Shakirzyanova; Stina Leskelä; Timo Sarajärvi; Matti Viitanen; Juha O Rinne; Mikko Hiltunen; Annakaisa Haapasalo; Rashid Giniatullin; Pasi Tavi; Su-Chun Zhang; Katja M Kanninen; Riikka H Hämäläinen; Jari Koistinaho
Journal:  Stem Cell Reports       Date:  2017-11-16       Impact factor: 7.765

10.  Creation of a library of induced pluripotent stem cells from Parkinsonian patients.

Authors:  Staffan Holmqvist; Šárka Lehtonen; Margarita Chumarina; Katja A Puttonen; Carla Azevedo; Olga Lebedeva; Marika Ruponen; Minna Oksanen; Mehdi Djelloul; Anna Collin; Stefano Goldwurm; Morten Meyer; Maria Lagarkova; Sergei Kiselev; Jari Koistinaho; Laurent Roybon
Journal:  NPJ Parkinsons Dis       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.